In recent years, precision medical detection techniques experienced a rapid transformation from low-throughput to high-throughput genomic sequencing, from multicell promiscuous detection to single-cell precision sequencing. The emergence of liquid biopsy technology has compensated for the many limitations of tissue biopsy, leading to a tremendous transformation in precision detection. Precision detection techniques contribute to monitoring disease development more closely, evaluating therapeutic effects more scientifically, and developing new targets and new drugs. In the future, the role of precision detection and the joint detection in epigenetics, rare gene detection, individualized targeted therapy, and multigene targeted drug combinati...
In the era of precision medicine, the use of molecularly targeted therapies in selected patients has...
In the context of oncology, liquid biopsies consist of harvesting cancer biomarkers, such as circula...
Ever since the first human genome was sequenced in 2001, there has been growing investment and resea...
Despite major therapeutic progress, most advanced solid tumors are still incurable. Cancer intercept...
The Rosetta Stone of the new era of biomedicine includes five essential ideas to understand the real...
Cancer remains a leading cause of death worldwide, despite many advances in diagnosis and treatment....
Over the last decades, the concept of precision medicine has dramatically renewed the field of medic...
With the popularization of molecular targeted drugs, precision medicine is gradually applied in canc...
Precision medicine is at the forefront of innovation in cancer care. With the development of technol...
Abstract The number of druggable tumor-specific molecular aberrations has grown substa...
Liquid biopsy for biomarker detection has the potential to revolutionise the management of cancer by...
Abstract Robust and clinically convenient biomarkers for cancer diagnosis, early detection, and prog...
Historically, studies of disseminated tumour cells in bone marrow and circulating tumour cells in pe...
Cancer is a lethal disease and ranks as the world’s second most prevalent cause of death. So far, ti...
Early diagnosis of cancer can significantly improve treatment and survival outcomes. Imaging and tis...
In the era of precision medicine, the use of molecularly targeted therapies in selected patients has...
In the context of oncology, liquid biopsies consist of harvesting cancer biomarkers, such as circula...
Ever since the first human genome was sequenced in 2001, there has been growing investment and resea...
Despite major therapeutic progress, most advanced solid tumors are still incurable. Cancer intercept...
The Rosetta Stone of the new era of biomedicine includes five essential ideas to understand the real...
Cancer remains a leading cause of death worldwide, despite many advances in diagnosis and treatment....
Over the last decades, the concept of precision medicine has dramatically renewed the field of medic...
With the popularization of molecular targeted drugs, precision medicine is gradually applied in canc...
Precision medicine is at the forefront of innovation in cancer care. With the development of technol...
Abstract The number of druggable tumor-specific molecular aberrations has grown substa...
Liquid biopsy for biomarker detection has the potential to revolutionise the management of cancer by...
Abstract Robust and clinically convenient biomarkers for cancer diagnosis, early detection, and prog...
Historically, studies of disseminated tumour cells in bone marrow and circulating tumour cells in pe...
Cancer is a lethal disease and ranks as the world’s second most prevalent cause of death. So far, ti...
Early diagnosis of cancer can significantly improve treatment and survival outcomes. Imaging and tis...
In the era of precision medicine, the use of molecularly targeted therapies in selected patients has...
In the context of oncology, liquid biopsies consist of harvesting cancer biomarkers, such as circula...
Ever since the first human genome was sequenced in 2001, there has been growing investment and resea...